Kim, C., Dinan, M. A., Robinson, T. J., Ross, J. S., Jastreboff, A. M., Krumholz, H. M., & Lu, Y. (2025). Semaglutide and Tirzepatide Prescribing for Obesity in Patients With Preexisting Comorbid Cancers. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2025.4560

Kim, Chungsoo, Michaela A. Dinan, Timothy J. Robinson, Joseph S. Ross, Ania M. Jastreboff, Harlan M. Krumholz, and Yuan Lu. “Semaglutide and Tirzepatide Prescribing for Obesity in Patients With Preexisting Comorbid Cancers.” JAMA Oncol, November 6, 2025. https://doi.org/10.1001/jamaoncol.2025.4560.

Kim C, Dinan MA, Robinson TJ, Ross JS, Jastreboff AM, Krumholz HM, et al. Semaglutide and Tirzepatide Prescribing for Obesity in Patients With Preexisting Comorbid Cancers. JAMA Oncol. 2025 Nov 6;

Kim, Chungsoo, et al. “Semaglutide and Tirzepatide Prescribing for Obesity in Patients With Preexisting Comorbid Cancers.” JAMA Oncol, Nov. 2025. Pubmed, doi:10.1001/jamaoncol.2025.4560.

Kim C, Dinan MA, Robinson TJ, Ross JS, Jastreboff AM, Krumholz HM, Lu Y. Semaglutide and Tirzepatide Prescribing for Obesity in Patients With Preexisting Comorbid Cancers. JAMA Oncol. 2025 Nov 6;